Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 174 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Haffajee RL, Mello MM. Drug companies’ liability for the opioid epidemic. N Engl J Med 2017;377:2301-5. [Ref.ID 102168]
3. Cita con resumen
Habibi R, Lexchin J, Mintzes B, Holbrook A. Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?. Br J Clin Pharmacol 2017;83:2549-56. [Ref.ID 102116]
7. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
8. Cita con resumen
Thomas K. Celgene to pay $280 Million to settle fraud suit over cancer drugs. N Y Times (Print) 2017:1. [Ref.ID 101924]
9. Cita con resumen
Armstrong D. Kentucky Senate president urges release of secret OxyContin records. STAT 2017:28 de junio. [Ref.ID 101657]
10. Cita con resumen
Anónimo. Gilead’s hepatitis C drug sales decline. DIA Daily 2016:11. [Ref.ID 100874]
11. Cita con resumen
13. Cita con resumen
Fleischman W, Agrawal S, King M, Venkatesh AK, Krumholz HM, McKee D, Brown D, Ross JS. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. BMJ 2016;354:i4189. [Ref.ID 100605]
14.Enlace a cita original Cita con resumen
Anónimo. La falsa transparencia y el lavado de cara de la industria farmacéutica. NoGracias 2016:1 de julio. [Ref.ID 100507]
16. Cita con resumen
Dyer O. Physician whistleblower is awarded $59m in Pfizer settlement. BMJ 2016;352:i1195. [Ref.ID 100326]
17. Cita con resumen
Anónimo. Valeant “predatorily priced” female libido drug, investors claim. DIA Daily 2016:1. [Ref.ID 100042]
18. Cita con resumen
McCarthy M. Novartis agrees to pay $390m in US kickback case. BMJ 2015;351:h5784. [Ref.ID 99637]
19. Cita con resumen
Anónimo. Drug problems: dangerous decision-making at the FDA. POGO. Project on Government Oversight 2015:15 de octubre. [Ref.ID 99569]
20. Cita con resumen
Anónimo. Teva Pharmaceuticals settles FTC’s claim against Cephalon for $1.2 billion. DIA Daily 2015:29 de mayo. [Ref.ID 99107]
Seleccionar todas
 
 1 a 20 de 174 siguiente >>